Stemtech (STEK) Operating Margin (2021 - 2025)

Stemtech has disclosed Operating Margin across 5 years of filings, most recently posting 217.12% for Q4 2025.

• Operating Margin for Q4 2025 came in at 217.12%, up 9325.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 29.57% (down 1389.0% YoY), and the FY2025 annual result was 29.57%, down 1389.0% from the prior year.
• Operating Margin came in at 217.12% for Q4 2025 at Stemtech, up from 39.8% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 259.19% in Q4 2022 to a low of 323.05% in Q3 2022.
• The 5-year median for Operating Margin is 48.41% (2023), against an average of 25.35%.
• Across the five-year window, Operating Margin slumped 24201 bps in 2022 and jumped 27845 bps in 2023, its largest moves.
• Stemtech's Operating Margin stood at 7.94% in 2021, then surged by 3363 bps to 259.19% in 2022, then sank by 53 bps to 121.67% in 2023, then advanced by 2 bps to 123.87% in 2024, then jumped by 75 bps to 217.12% in 2025.
• The last three Operating Margin figures came in at 217.12% (Q4 2025), 39.8% (Q3 2025), and 43.13% (Q2 2025), per Business Quant data.